Transfusion Medicine Reviews
Volume 17, Issue 2 , Pages 120-162, April 2003

Risks associated with transfusion of cellular blood components in canada☆☆☆★★★

University of British Columbia, Vancouver BC, Canada; Kleinman Biomedical Research, Victoria BC, Canada; Private Consultant, Toronto, Ontario, Canada; the Hemovigilance Research Unit, Quebec Public Health Institute, and the Departments of Epidemiology and Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This document represents the work of individuals and is not an official document of the National Blood Safety Council or the Quebec Public Health Institute.

☆☆ Funded by an unrestricted educational grant from the Hemosol Corporation.

★ Address reprint requests to Steven Kleinman, MD, 1281 Rockcrest Avenue, Victoria, BC, V9A-4W4 Canada.

★★ 0887-7963/03/1702-0004$30.00/0

PII: S0887-7963(03)90003-4

doi:10.1016/S0887-7963(03)90003-4

Transfusion Medicine Reviews
Volume 17, Issue 2 , Pages 120-162, April 2003

Article Tools